GlaxoSmithKline Pharmaceuticals has revised the meeting of the Board of Directors which was scheduled to be held on 10 February 2025. The meeting will now be held on 14 February 2025.Powered by Capital Market - Live News

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 February 2025.Powered by Capital Market - Live News

Net profit of Glaxosmithkline Pharmaceuticals rose 16.09% to Rs 252.50 crore in the quarter ended September 2024 as against Rs 217.51 crore during the previous quarter ended September 2023. Sales rose 5.62% to Rs 1010.77 crore in the quarter ended September 2024 as against Rs 956.99 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1010.77956.99 6 OPM %31.8330.25 - PBDT355.98317.27 12 PBT339.12299.16 13 NP252.50217.51 16 Powered by Capital Market - Live News

GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 29 October 2024, has recommended a Special Interim dividend of Rs.12 per share (i.e.120%), subject to the approval of the shareholders.Powered by Capital Market - Live News

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 October 2024.Powered by Capital Market - Live News